(Q38469677)

3 September 2017

title

Loss of heterozygosity of BRCA1, TP53 and TCRD markers analysed in sporadic endometrial cancer (English)

1 reference

3 September 2017

1 reference

10

Beckmann MW

1 reference

3 September 2017

Niederacher D

1

1 reference

3 September 2017

An HX

2

1 reference

3 September 2017

Camrath S

3

1 reference

3 September 2017

Dominik SI

4

1 reference

3 September 2017

Göhring UJ

5

1 reference

3 September 2017

Oertel A

6

1 reference

3 September 2017

Grass M

7

1 reference

3 September 2017

Hantschmann P

8

1 reference

3 September 2017

Lordnejad MR

9

1 reference

3 September 2017

publication date

1 October 1998

1 reference

European Journal of Cancer

3 September 2017

published in

1 reference

3 September 2017

volume

34

1 reference

3 September 2017

issue

11

1 reference

3 September 2017

page(s)

1770-1776

1 reference

Management of endometrial cancer

3 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900270-6

7 January 2021

Prognostic factors that predict pelvic lymph node metastasis from endometrial carcinoma.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900270-6

7 January 2021

Prognostic value of DNA ploidy and S-phase fraction in endometrial cancer stage I and II: a prospective 5-year survival study

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900270-6

7 January 2021

Multivariable analysis of DNA ploidy, p53, and HER-2/neu as prognostic factors in endometrial cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900270-6

7 January 2021

Steroid receptors and clinical outcome in patients with adenocarcinoma of the endometrium

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900270-6

7 January 2021

Prognostic significance of steroid receptors measured in primary metastatic and recurrent endometrial carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900270-6

7 January 2021

Growth factors and steroid hormone action in endometrial cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900270-6

7 January 2021

Overexpression of HER-2/neu in endometrial cancer is associated with advanced stage disease

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900270-6

7 January 2021

HER-2/neu expression: a major prognostic factor in endometrial cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900270-6

7 January 2021

Expression of EGFR, HER-2/neu, P53, and PCNA in endometrioid, serous papillary, and clear cell endometrial adenocarcinomas

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900270-6

7 January 2021

The p53 tumor suppressor gene frequently is altered in gynecologic cancers

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900270-6

7 January 2021

Identification of p53 mutations by means of single strand conformation polymorphism analysis in gynaecological tumours: comparison with the results of immunohistochemistry

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900270-6

7 January 2021

Molecular basis of endometrial cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900270-6

7 January 2021

Studies on ras oncogene activation in endometrial carcinoma.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900270-6

7 January 2021

Microsatellite instability in sporadic endometrial carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900270-6

7 January 2021

DCC gene alteration in human endometrial carcinomas

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900270-6

7 January 2021

Allelotype of uterine cancer by analysis of RFLP and microsatellite polymorphisms: frequent loss of heterozygosity on chromosome arms 3p, 9q, 10q, and 17p.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900270-6

7 January 2021

Observations on tumor and metastatic suppressor gene status in endometrial carcinoma with particular emphasis on p53

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900270-6

7 January 2021

A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900270-6

7 January 2021

Human familial and sporadic breast cancer: analysis of the coding regions of the 17 beta-hydroxysteroid dehydrogenase 2 gene (EDH17B2) using a single-strand conformation polymorphism assay

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900270-6

7 January 2021

Human 17 beta-hydroxysteroid dehydrogenase type 1 and type 2 isoenzymes have opposite activities in cultured cells and characteristic cell- and tissue-specific expression

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900270-6

7 January 2021

Immunohistochemical detection of epidermal growth factor receptor (EGF-R) in paraffin sections of breast carcinoma tissue: correlation and clinical significance

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900270-6

7 January 2021

Patterns of allelic loss on chromosome 17 in sporadic breast carcinomas detected by fluorescent-labeled microsatellite analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900270-6

7 January 2021

ERBB2 gene amplification detected by fluorescent differential polymerase chain reaction in paraffin‐embedded breast carcinoma tissues

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900270-6

7 January 2021

Heterogeneity for Allelic Loss in Human Breast Cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900270-6

7 January 2021

Rapid detection of allele loss in colorectal tumours using microsatellites and fluorescent DNA technology

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900270-6

7 January 2021

Hereditary breast cancer and family cancer syndromes

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900270-6

7 January 2021

Family history and the risk of endometrial cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900270-6

7 January 2021

A comparative study of risk factors for hyperplasia and cancer of the endometrium

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900270-6

7 January 2021

10.1016/S0959-8049(98)00270-6

Identifiers

DOI

1 reference

3 September 2017

1 reference